These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25130039)

  • 1. Tissue kallikrein-kinin therapy in hypertension and organ damage.
    Chao J; Bledsoe G; Chao L
    Prog Drug Res; 2014; 69():37-57. PubMed ID: 25130039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.
    Chao J; Shen B; Gao L; Xia CF; Bledsoe G; Chao L
    Biol Chem; 2010 Apr; 391(4):345-55. PubMed ID: 20180644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kallikrein-kinin pathways in hypertension and diabetes.
    Sharma JN; Narayanan P
    Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal (tissue) kallikrein-kinin system in the kidney and novel potential drugs for salt-sensitive hypertension.
    Katori M; Majima M
    Prog Drug Res; 2014; 69():59-109. PubMed ID: 25130040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental therapy with tissue kallikrein against cerebral ischemia.
    Chao J; Chao L
    Front Biosci; 2006 May; 11():1323-7. PubMed ID: 16368519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.
    Sharma JN
    Arch Med Res; 2006 Apr; 37(3):299-306. PubMed ID: 16513476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases.
    Girolami JP; Blaes N; Bouby N; Alhenc-Gelas F
    Prog Drug Res; 2014; 69():145-96. PubMed ID: 25130042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
    Yao YY; Yin H; Shen B; Chao L; Chao J
    J Card Fail; 2007 Sep; 13(7):588-96. PubMed ID: 17826650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation.
    Chao J; Yin H; Gao L; Hagiwara M; Shen B; Yang ZR; Chao L
    Hypertension; 2008 Oct; 52(4):715-20. PubMed ID: 18768400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases.
    Schremmer-Danninger E; Naidoo S; Neuhof C; Valeske K; Snyman C; Sander C; Bhoola KD; Neuhof H
    Biol Chem; 2004 Nov; 385(11):1069-76. PubMed ID: 15576327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
    Bledsoe G; Crickman S; Mao J; Xia CF; Murakami H; Chao L; Chao J
    Nephrol Dial Transplant; 2006 Mar; 21(3):624-33. PubMed ID: 16401625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC; Yoshida H; Agata J; Chao L; Chao J
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kallikrein-kinin system and oxidative stress.
    Kayashima Y; Smithies O; Kakoki M
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):92-6. PubMed ID: 22048723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
    Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue kallikrein and kinins in renal disease.
    Naicker S; Naidoo S; Ramsaroop R; Moodley D; Bhoola K
    Immunopharmacology; 1999 Oct; 44(1-2):183-92. PubMed ID: 10604543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin B1 Receptor Signaling in Skin Homeostasis and Wound Healing.
    Matus CE; Bhoola KD; Figueroa CD
    Yale J Biol Med; 2020 Mar; 93(1):175-185. PubMed ID: 32226346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
    Moodley R; Snyman C; Odhav B; Bhoola KD
    Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.